Recent Quarter Total Invested
$14.21 B
Recent Quarter Institutional Ownership Percentage
93.9%
Total Invested of Last Quarter
$10.57 B
Ownership Percentage of Last Quarter
86.91%
Sarepta Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 10.32 M | $1.63 B | 73.22% | 10.98% |
| VANGUARD GROUP INC | 08/13/2024 | 9.04 M | $1.43 B | 2.73% | 9.61% |
| CAPITAL INTERNATIONAL INVESTORS | 08/13/2024 | 4.32 M | $682.69 M | -10.31% | 4.60% |
| STATE STREET CORP | 08/14/2024 | 4.14 M | $654.40 M | 95.14% | 4.41% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 3.82 M | $602.74 M | -22.00% | 4.06% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 3.00 M | $474.00 M | -30.95% | 3.19% |
| MORGAN STANLEY | 10/17/2024 | 2.62 M | $414.49 M | 195.28% | 2.79% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 2.30 M | $362.61 M | -6.46% | 2.44% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 2.13 M | $336.64 M | 3.08% | 2.27% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 2.06 M | $325.72 M | -36.49% | 2.19% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.96 M | $309.47 M | 1.40% | 2.08% |
| FMR LLC | 08/13/2024 | 1.86 M | $293.97 M | 37.96% | 1.98% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.84 M | $291.32 M | 0.83% | 1.96% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.65 M | $261.09 M | 8.66% | 1.76% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.57 M | $248.63 M | 7.74% | 1.67% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 1.41 M | $222.36 M | -26.70% | 1.50% |
| CASDIN CAPITAL, LLC | 10/18/2024 | 1.07 M | $169.61 M | 0.42% | 1.14% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 957,218 | $151.24 M | -23.94% | 1.02% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 947,574 | $149.72 M | -12.13% | 1.01% |
| NORGES BANK | 08/14/2024 | 924,428 | $146.06 M | 100.00% | 0.98% |
| JANE STREET GROUP, LLC | 08/15/2024 | 869,129 | $137.32 M | 212.52% | 0.92% |
| CITADEL ADVISORS LLC | 08/14/2024 | 775,821 | $122.58 M | -49.06% | 0.83% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 721,401 | $113.98 M | 10.40% | 0.77% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 720,800 | $113.89 M | 114.59% | 0.77% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 690,408 | $109.08 M | 19.11% | 0.73% |
| NORTHERN TRUST CORP | 08/14/2024 | 668,078 | $105.56 M | 55.07% | 0.71% |
| BOXER CAPITAL, LLC | 08/14/2024 | 650,000 | $102.70 M | 0.00% | 0.69% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 646,000 | $102.07 M | -7.38% | 0.69% |
| THRIVENT FINANCIAL FOR LUTHERANS | 08/13/2024 | 644,675 | $101.86 M | 6.25% | 0.69% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 606,834 | $95.88 M | -8.24% | 0.65% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 604,757 | $95.55 M | 2.60% | 0.64% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 601,200 | $94.99 M | -15.63% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 572,275 | $90.42 M | -34.53% | 0.61% |
| ALKEON CAPITAL MANAGEMENT LLC | 08/14/2024 | 558,845 | $88.30 M | 21.79% | 0.59% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 541,794 | $85.60 M | 58.10% | 0.58% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 532,918 | $84.20 M | 4.66% | 0.57% |
| FEDERATED HERMES, INC. | 08/08/2024 | 508,329 | $80.32 M | -16.70% | 0.54% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 500,000 | $79.00 M | -58.33% | 0.53% |
| ROYAL BANK OF CANADA | 08/14/2024 | 495,540 | $78.29 M | 7.58% | 0.53% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 483,235 | $76.35 M | -10.94% | 0.51% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 439,577 | $69.45 M | 75.80% | 0.47% |
| EAGLE ASSET MANAGEMENT INC | 08/12/2024 | 406,046 | $63.65 M | 90.25% | 0.43% |
| BARCLAYS PLC | 08/14/2024 | 400,898 | $63.34 M | 4.00% | 0.43% |
| TWIN TREE MANAGEMENT, LP | 08/13/2024 | 400,600 | $63.29 M | 100.00% | 0.43% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 400,000 | $63.20 M | -14.89% | 0.43% |
| MAN GROUP PLC | 08/14/2024 | 386,424 | $61.05 M | 222.01% | 0.41% |
| CITADEL ADVISORS LLC | 08/14/2024 | 386,100 | $61.00 M | 16.61% | 0.41% |
| FIERA CAPITAL CORP | 10/31/2024 | 382,645 | $60.46 M | 4.25% | 0.41% |
| INVESCO LTD. | 08/13/2024 | 380,377 | $60.10 M | 262.39% | 0.40% |
| PRINCIPAL FINANCIAL GROUP INC | 07/29/2024 | 363,011 | $57.36 M | 693.74% | 0.39% |
Sarepta Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of SRPT shares?
During the previous two years, 523 institutional investors and hedge funds held shares of Sarepta Therapeutics, Inc.. The most heavily invested institutionals were:
Concord Wealth Partners: 0
GPS Wealth Strategies Group, LLC: 0
HARBOR INVESTMENT ADVISORY, LLC: 0
Vanguard Capital Wealth Advisors: 0
Blackston Financial Advisory Group, LLC: 0
ROMAN BUTLER FULLERTON & CO: 0
-
What percentage of Sarepta Therapeutics, Inc. stock is owned by institutional investors?
93.90% of Sarepta Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at SRPT ?
Institutional investors have bought a total of 95.70 M shares in the last 24 months. This purchase volume represents approximately $11.94 B in transactions.